The Next Phase of Pharmacogenomics, Washington, DC, USA
Event Sep 27
Attend CBI’s The Next Phase of Pharmacogenomics and abreast yourself with the evolving phenomena of modern drug development.
·Explore pharmacgoengomics in clinical trials
·Examine how pharmacogenomics is being utilized in special therapies
·Learn the impact of recent FDA guidance of the use of pharmacogenomics data, "pharmacogenomics data submission guidance" on the future of targeted medicine and the industry
·Examine the international regulatory environment and the impact on pharmacogenomics deployment and the industry in Europe
·Discuss the benefits of pharmacogenomics, barriers to its progress and challenges for the future